Healthcare provider profile · identity verified

Theodore R Cubbison, DO

Internal Medicine · YOUNGSTOWN, OH · NPI 1871595603

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	503	127
Amlodipine Besylate	Amlodipine Besylate	485	109
Lisinopril	Lisinopril	360	85
Albuterol Sulfate Hfa	Albuterol Sulfate	326	82
Gabapentin	Gabapentin	309	61
Levothyroxine Sodium	Levothyroxine Sodium	303	70
Omeprazole	Omeprazole	289	77
Metformin Hcl	Metformin Hcl	260	58
Metoprolol Succinate	Metoprolol Succinate	243	59
Rosuvastatin Calcium	Rosuvastatin Calcium	239	58
Jardiance	Empagliflozin	208	43
Pantoprazole Sodium	Pantoprazole Sodium	178	44
Furosemide	Furosemide	172	42
Trazodone Hcl	Trazodone Hcl	165	44
Losartan Potassium	Losartan Potassium	157	38
Hydrochlorothiazide	Hydrochlorothiazide	139	38
Duloxetine Hcl	Duloxetine Hcl	138	26
Tamsulosin Hcl	Tamsulosin Hcl	134	28
Trulicity	Dulaglutide	130	29
Potassium Chloride	Potassium Chloride	128	26
Eliquis	Apixaban	126	24
Farxiga	Dapagliflozin Propanediol	126	22
Metoprolol Tartrate	Metoprolol Tartrate	125	26
Ozempic	Semaglutide	125	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	119	31
Citalopram Hbr	Citalopram Hydrobromide	116	24
Simvastatin	Simvastatin	107	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	106	25
Ibuprofen	Ibuprofen	105	30
Fluticasone Propionate	Fluticasone Propionate	103	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	102	30
Tramadol Hcl	Tramadol Hcl	102	21
Meloxicam	Meloxicam	97	17
Quetiapine Fumarate	Quetiapine Fumarate	92	16
Montelukast Sodium	Montelukast Sodium	91	20
Clopidogrel	Clopidogrel Bisulfate	86	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	14
Sertraline Hcl	Sertraline Hcl	76	16
Pravastatin Sodium	Pravastatin Sodium	75	16
Donepezil Hcl	Donepezil Hcl	72	15
Famotidine	Famotidine	70	17
Atenolol	Atenolol	68	14
Ezetimibe	Ezetimibe	68	21
Symbicort	Budesonide/Formoterol Fumarate	67	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	66	52
Finasteride	Finasteride	65	suppressed
Alendronate Sodium	Alendronate Sodium	63	14
Glipizide Er	Glipizide	63	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	15
Acarbose	Acarbose	56	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	55	suppressed
Spiriva Respimat	Tiotropium Bromide	55	18
Pioglitazone Hcl	Pioglitazone Hcl	54	suppressed
Ropinirole Hcl	Ropinirole Hcl	54	suppressed
Xarelto	Rivaroxaban	51	suppressed
Ondansetron Hcl	Ondansetron Hcl	48	15
Hydroxyzine Hcl	Hydroxyzine Hcl	47	16
Carvedilol	Carvedilol	44	13
Diclofenac Sodium	Diclofenac Sodium	44	15
Spironolactone	Spironolactone	44	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Buspirone Hcl	Buspirone Hcl	42	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	42	12
Lovastatin	Lovastatin	41	suppressed
Prednisone	Prednisone	40	20
Glipizide	Glipizide	38	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Glimepiride	Glimepiride	35	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Topiramate	Topiramate	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	11
Diazepam	Diazepam	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Creon	Lipase/Protease/Amylase	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Fluconazole	Fluconazole	23	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Methylprednisolone	Methylprednisolone	21	18
Valacyclovir	Valacyclovir Hcl	21	suppressed
Ibu	Ibuprofen	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Invokana	Canagliflozin	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Lidocaine	Lidocaine	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Azithromycin	Azithromycin	14	14
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Etodolac	Etodolac	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Acetazolamide	Acetazolamide	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Baclofen	Baclofen	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Trulance	Plecanatide	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Vraylar	Cariprazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error